Differential effects of Staphylococcal enterotoxin B-mediated immune activation on intestinal defensins

Clinical and Experimental Immunology

Volumn 156, Issue 2, 2009, Pages 263-270

  Dhaliwal, W ^a   Kelly, P ^a   Bajaj Elliott, M ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Defensin; Inflammation; Intestine; Mucosal immunity

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; DEFENSIN; DEXAMETHASONE; GAMMA INTERFERON; HUMAN DEFENSIN 5; HUMAN DEFENSIN 6; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; STAPHYLOCOCCUS ENTEROTOXIN A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DUODENUM; DUODENUM BIOPSY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; T LYMPHOCYTE ACTIVATION; TISSUE CULTURE;

ADULT; ALPHA-DEFENSINS; BETA-DEFENSINS; DEFENSINS; DEXAMETHASONE; DUODENITIS; DUODENUM; ENTEROTOXINS; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; RNA, MESSENGER; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC; SUPERANTIGENS; TISSUE CULTURE TECHNIQUES;

EID: 64649094996     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03808.x     Document Type: Article

References (35)

1. World Health Organization. Global health - today's challenges. Geneva : The World Health Report, 2003.
2. Dommett R, Zilbauer M, George JT, Bajaj-Elliott M. Innate immune defence in the human gastrointestinal tract. Mol Immunol 2005 42 : 903 12.
3. Menendez A, Brett Finlay B. Defensins in the immunology of bacterial infections. Curr Opin Immunol 2007 19 : 385 91.
4. Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007 23 : 370 78.
5. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992 267 : 23216 25.
6. Jones DE, Bevins CL. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defence of the human bowel. FEBS Lett 1993 315 : 187 92.
7. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997 387 : 861.
8. Garcia JR, Krause A, Schulz S et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001 15 : 1819 21.
9. Wehkamp J, Salzman NH, Porter E et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005 102 : 18129 34.
10. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 2007 19 : 70 83.
11. Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008 57 : 903 10.
12. Wilson CL, Ouellette AJ, Satchell DP et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defence. Science 1999 286 : 113 7.
13. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003 422 : 522 6.
14. Dhaliwal W, Bajaj-Elliott M, Kelly P. Intestinal defensin gene expression in human populations. Mol Immunol 2003 40 : 469 75.
15. Kelly P, Menzies I, Crane R et al. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 2004 70 : 412 9.
16. Veitch AM, Kelly P, Zulu IS, Segal I, Farthing MJ. Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol 2001 13 : 1175 81.
17. Campbell DI, Murch SH, Elia M et al. T cell-mediated enteropathy in rural West African children: relationship with nutritional status and small bowel function. Pediatr Res 2003 54 : 306 11.
18. Bajaj-Elliott M, Fedeli P, Smith GV et al. Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis. Gut 2002 51 : 356 61.
19. Kelly P, Bajaj-Elliott M, Katubulushi M et al. Reduced gene expression of intestinal alpha-defensins predicts diarrhea in a cohort of African adults. J Infect Dis 2006 193 : 1464 70.
20. Pender SL, Breese EJ, Gunther U et al. Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases. Gastroenterology 1998 115 : 573 83.
21. Khan AA, Martin S, Saha B. SEB-induced signalling in macrophages leads to biphasic TNFα. J Leukoc Biol 2008 83 : 1363 9.
22. Yang PC, Xing Z, Berin CM et al. TIM-4 expressed by mucosal dendritic cells plays a critical role in food-antigen specific Th2 differentiation and intestinal allergy. Gastroenterology 2007 133 : 1522 33.
23. Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004 53 : 1658 64.
24. van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiemstra PS. Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res 2002 51 : 8 15.
25. Duits LA, Rademaker M, Ravensbergen B et al. Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids. Biochem Biophys Res Commun 2001 280 : 522 5.
26. Jang BC, Lim KJ, Suh MH, Park JG, Suh SI. Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-kappaB transcriptional factor in A549 cells. FEMS Immunol Med Microbiol 2007 51 : 171 84.
27. Mallow EB, Harris A, Salzman N et al. Human enteric defensins. Gene structure and developmental expression. J Biol Chem 1996 271 : 4038 45.
28. Wehkamp J, Wang G, Kübler I et al. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007 179 : 3109 18.
29. Sayama K, Komatsuzawa H, Yamasaki K et al. New mechanisms of skin innate immunity: ASK1-mediated keratinocyte differentiation regulates the expression of beta-defensins, LL37, and TLR2. Eur J Immunol 2005 35 : 1886 95.
30. Bullard RS, Gibson W, Bose SK et al. Functional analysis of the host defensin peptide human ß-defensin 1: new insight into its potential role in cancer. Mol Immunol 2008 45 : 839 48.
31. Islam D, Bandholtz L, Nilsson J et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001 7 : 180 5.
32. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V. Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 2004 72 : 2772 9.
33. O'Neil DA, Porter EM, Elewaut D et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999 163 : 6718 24.
34. Kanda N, Watanabe S. IL-12, IL-23 and IL-27 enhance human beta defensin 2 production in human keratinocytes. Eur J Immunol 2008 38 : 1287 96.
35. Kao CY, Chen Y, Thai P et al. IL-17 markedly upregulates beta defensin 2 expression in human airway epithelium via JAK and NF-κB signalling pathways. J Immunol 2004 173 : 3482 91.